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Abstract: Building on the works of sociologists of health and illness that have highlighted the 
effects of visible difference and stigmatisation since Goffman, this article examines the 
ambivalence of visibility experienced by people with cystic fibrosis (CF), a fatal chronic disease 
and the artful tactics they employ in carving out a habitable space in an ableist world. Dealing 
with the ambivalence of being at once inherently ill and apparently healthy is a process of giving 
constant care and attention to one’s body and its presence in public, and if successful, enabling 














Anthropologists have directed our attention 
to the struggles of marginalized individuals 
and groups like those with a chronic illnesses 
to gain greater public visibility of their 
therapeutic burden. Yet, only modest 
attention has been paid to the efforts put into 
achieving a visible normality through 
therapeutic practices or to the therapeutic 
work behind this apparent normality (Robbins 
2013; Ortner 2016). 
We present here the results of a longterm 
anthropological study in collaboration with a 
group of adolescents and young adults who 
have cystic fibrosis, a fatal genetic condition. 
Through fieldwork in Berlin, Germany, we 
explored how young people – who often do 
not readily appear to be sick – integrate 
therapy into their daily lives (Jorgenson 1989).  
Building on the works of sociologists of health 
and illness that have highlighted the effects of 
visible difference and stigmatisation (Goffman 
1969; Yang, Kleinman, Link et al. 2006), this 
article examines the ambivalence of visibility 
experienced by people with CF. We extend 
the conceptual framework put forward by 
Michel de Certeau (1980) in his studies of the 
practices of everyday life of marginalized 
people to those living with a chronic illness to 
show the artful tactics they employ in carving 
out a habitable space in an ableist world.  
We follow the story of a group of young 
people we met in 2007 at an outpatient clinic, 




and re-encountered several times over the 
last 10 years. As both anthropologists and 
doctors, we are interested in their struggle for 
well-being, care and with morality (Mijazaki 
2004).  
 
Living with CF 
It was a warm summer day in Berlin. Tanja (a 
pseudonym) and I met at a photography 
exhibit in the city centre. She was one of the 
young adults with Cystic Fibrosis we followed 
in the course of our research. At the entrance 
to the exhibit, Tanja flashed her disability card 
and asked for free entry for herself and one of 
us as her “accompanying person”. The young 
man at the desk looked at Tanja with 
hesitation, his eyes moving between Tanja 
and the card she held in her hand. He seemed 
to be assessing whether Tanja was attempting 
to elicit a benefit to which she was not 
entitled. Tanja was an good-looking young 
woman in her early twenties. She spoke 
quickly and confidently in a way that troubles 
categorizations like healthy/ill, able/disabled, 
and the tendency to equate illness and 
unattractiveness (Hall 1997). Tanja didn't fit 
the stereotypical image of a disabled person 
who requires someone to accompany her. By 
using the card, she transgressed forms and 
expectations, rendering her in some ways un-
intelligible and difficult to “sort out” (Bowker 
& Star 1999). This un-intelligibility is a part of 
the burden of living each day as a young 
person with a fatal chronic illness (Badlan 
2006; Williams et al. 2009) 
 
CF is a rare genetic disease that causes 
frequent respiratory infections, leading to 
progressive scarring of the lung tissue. Most 
people with CF will start their therapy in the 
first years of life and will require a lung 
transplant at some point in their lives; those 
who do not receive a transplant often die 
from suffocation. There is currently no cure 
for CF, but its progression can be slowed 
(Ratjen & Döring, 2003). In Europe and North 
America, the life expectancy of someone with 
CF is approximately 38 years and it has been 
continuously rising in the last decades from 
around 15 years in the 1960. Responsible for 
this increasing survival is not a single new 
drug, but a more complex and demanding 
therapeutic regimen (Davis 2006; CFF 2009). 
It involves approximately 2 hours of 
inhalation and chest physiotherapy every day, 
and up to 7 different oral medications 
(Sawicki et al. 2009). Patients consider this 
therapeutic regime as burdensome and time 
consuming, and treatment is seen as marker 
of illness and stigmatising (Bregnballe 2011). 
Especially for adolescents and young adults it 
is a continuous challenge to integrate the 
therapeutic regimen into daily life with school 
or work, family, friends, and leisure activities 
(Staab et al 1998). Faced with the possibility 
to be part of their peers, young people with 
CF employ an arsenal of tactics to hide the 
work behind their normal apparence (Ernst, 
Johnson & Stark 2010). 
Adherence to the therapeutic regimes is 
around 50% (Llorente et al 2008). While poor 
adherence to this complex therapy is 
recognised as the main cause of treatment 
failure and increased exacerbation rates 
(Eakin et al 2011), some authors suggest that 
educated non-adherence with a treatment 
may be an adaptive way of coping (Dodd & 
Webb 2000). Since nobody is able to be 100% 
compliant with long-term treatments, it 
seems reasonable to aim at 'educated non 
compliance', so the patient is capable to 
decide together with the CF team what is 
important for him and what could be skipped 
for a certain time. Patients and caregivers are 
balancing out which minimal therapy works 
for them at a certain moment (Havermans & 
de Boeck 2007). 
 
When care strikes back at normality  
  




The balancing act takes on particular 
significance if a therapeutic regime is very 
successful. As one physician told us during an 
interview: 
There may be moments when doing more 
therapy leads to better health, and at this 
point you reduce therapy – because 
everything goes well. Some patients are 
then able to lead a life undisturbed by 
therapy for a period of time. In such a 
moment of relative stable health even very 
little therapy can be very disruptive. 
 
In the last case referred to by the physician, 
the effect of increased therapy levels off and 
reaches a plateau. Economists would say from 
a certain point onwards, extra treatment has 
decreasing marginal utility. Patients whose 
health-state demands for a treatment burden 
beyond this plateau experience a double bind, 
like one of Tanya's friends: 
When I was still at primary school, some 
teachers sent me home when I was 
coughing, saying “come back when you are 
healthy”. But I would still be ill in a week! 
So, I realised that I didn’t have to cough as 
much if I didn’t inhale in the morning. 
Smart, aren’t I?  
 
The dynamic described by Tanja's friend is 
experienced by many other patients as 
'normality striking back at therapy'. To appear 
normal in a period of relatively stable health, 
therapy has to be absent. Although the young 
patient did her inhalation at home, she was 
still ill to her peers and teachers when she 
coughed in school. As coughing made her 
illness apparent, the therapy didn't work at 
that moment. Even if it would lead to better 
health in the long term, the adverse effect of 
inhalation therapy made illness visible. When 
more treatment leads to more symptoms, 
while less treatment leads to greater chances 
to spend time on activities with peers, 
skipping therapy seemed a rational choice. 
People in such a situation will generally want 
their condition to be invisible to the public. As 
they are at constant risk of outing themselves 
involuntarily, they have developed an arsenal 
of strategies for passing (Goffman 1963). 
Through therapy, they can render their illness 
invisible to the general public. Their illness is 
of course perceptible to themselves and to 
their doctors, and perhaps other patients. 
Some subtle signs like clubbing of the fingers 
that indicates lack of oxygen, a hump in the 
back that hints to overinflation of the lungs, a 
hoarse voice from inhaling and the salty taste 
when you kiss someone with CF will be put 
together by people that Goffman (1969) 
called “the wise“ - those that know the sings 
of an affliction by acquaintance. 
The difficulties related by the to “sort out” 
Tanja at the exhibition, or her friend at school 
reveals their double status as someone who is 
at once ill and apparently healthy (Bowker & 
Star 1999), but also the possibility to manage 
this double status by tactically revealing 
either status. 
 
CF therapy has traditionally taken place in 
hospitals. But, increasingly, the space of 
therapy is becoming fluid. With the help of 
procedures like inhalation, chest 
physiotherapy and the delivery of intravenous 
(IV) antibiotics, patients have gained 
opportunities. For this to occur, certain 
technical innovations were essential – such as 
replacing the standard and somewhat clumsy 
hospital infusion pump with a smaller one. 
Patients can slip this smaller pump into a 
trouser pocket, running the IV line under their 
shirtsleeve. Moving therapy out of the 
hospital means greater freedom for patients 
living with CF, but it also means that they 
have to integrate therapy into the practices of 
everyday life, particularly at home. 
 
Strategies and Tactics for managing the 
visibility of illness and therapy 




We follow here Michel de Certeau who 
differentiated tactics from strategies. 
Strategies are calculation of power relations 
that require a place, a basis for organising 
relations, while tactics cannot calculate with a 
won space, but have to use the space of the 
other, and cannot capitalise gains. A hospital 
or a research laboratory would be such places 
where doctors and patients can strategically 
develop and test therapies, devices or drugs. 
Outside a hospital, patients are only able to 
deploy their tactics at a “right moment” in 
order to control illness and it's visibility. Since 
tactics cannot be planed in advance, they 
require experience to recognise and capture 
the “right moment”. While strategies are 
dependent on the use of a place, tactics are 
dependent on the use of time (de Certeau 
1980:23).  
 
One frequently employed tactic is to disclose 
illness only to certain people. Knowledge 
about CF would be shared with close friends 
only and only rarely to casual encounters – 
like Tanja at the museum.(Borschuk et al. 
2016). Differential disclosure is employed to 
mitigate negative repercussions or negative 
consequences when disclosing to romantic 
partners and in the workplace (Modi et al. 
2010) As Tanja explained „Emotions are quite 
strong, I've been able to suppress the urge to 
cough for a really long time, when I came 
home at night with someone I didn't want to 
know of my CF.” While it is assumed that 
greater disclosure is associated with higher 
disease severity (Lowton 2004), here, we 
attempt a more fine grained analysis. Almost 
all patients we have worked with oscillate in 
their relation to CF. 'Being normal' and 'doing 
therapy' are modularised in space and time so 
as to manage their therapy in a way that CF 
does not reappear in public. While it is not 
possible to observe that in casual or clinical 
settings, participant observation at patients 
homes provided insights into how patients 
manage this. The remainder of this article is 
illustrating that way of coping. 
 
In Tanja's apartment, a handful of pills lay on 
the kitchen table. I recognized them as the 
pancreatic enzymes many young people with 
CF have to take with every meal so that they 
can absorb nutrients. On a nearby shelf, there 
were boxes of vitamins, anti-inflammatory 
drugs and antibiotics. Another box of 
antibiotics sat next to the cheese in the fridge. 
Beside a bookshelf was Tanja’s nebulizer, a 
handheld device the size of a small bottle. 
Through a mouthpiece on it's top, Tanja 
inhales hypertonic saline for up to 30 
minutes, two sessions per day in order to 
dilute the mucus that builds up in her lungs. 
 
On one of the many occasions when Tanja’s 
physiotherapist visited, talking was also part 
of the session. The two of them began by 
catching up on the latest news and events: 
patients who had gotten better lately or taken 
a turn for the worse, and their holiday plans. 
Only after socializing did Tanja lie down on 
the couch to begin chest-physiotherapy, a 
procedure that involves chest compression 
and decompression to mobilizes the mucus in 
the lungs that can then be coughed up slowly 
(image 2). During the treatment, Tanja’s face 
became red and the room was silent except 
for her repeated coughing. These moments of 
coughing were a stark contrast to the casual 
social encounter that began the 30 minute 
long session; suddenly, Tanja’s illness was 
starkly present. But, after one seemingly 
endless minute of exertion, Tanja spat the 
mucus into a small sealable container and the 
chatting continued. 
 
As in during the physiotherapy session, there 
is a constant blurring of lines between 
therapy and everyday life for young people 
living with CF today. Tanja and others 
described to me how the dramatic intensity of 




life with CF can lead to close relationships. 
Many patients have relationships with other 
patients, and sometimes marry. Patients and 
medical staff like to go to exhibitions and 
concerts or on vacations together. One doctor 
remembered being called on the phone in the 
middle of the night by a patient who had 
gotten lost on the highway while hitchhiking. 
Although initially patients like to keep 
distance between the hospital world and day 
to day life, with time they become 
increasingly entangled.  
But the value of participant observation based 
research are close relationsships and a 
becomming with participants (Ingold 2013). 
At the beginning of this project, I was warned 
by the staff at the CF clinic that they have 
seen several of their younger doctors become 
emotionally attached to patients who later 
died. During the first year of research, three 
of the 15 patients I followed passed away and 
several have since during attempted lung-
transplantation or while waiting for one. But 
the close relationships that were formed with 
some of the young adults we followed were 
fundamental to our anthropological work – 
and in some ways difficult to avoid in a 
research envisioned as a collaborative 
process. We were similar in age and interests 
to many of our collaborators; they, in turn, 
were often enthusiastic about reflecting on 
the ambivalence of their visibility in the 
context of our work together. 
 
That same night when her physiotherapist 
had visited, Tanja came out of her room 
before bed to put a gastric tube through her 
nose. She connected it to a bag of high-caloric 
food to ingest into her stomach while she 
sleeps. These extra calories are essential to 
meeting the increased energy demands 
experienced by people with CF, who 
experience a constant inflammation as a 
result of fighting chronic respiratory 
infections and generally have to work harder 
to breath. The gastric tube is not a 
comfortable procedure; in fact, Tanja knows 
of only few other people who do it. “I also 
usually do not show this to anyone,” she 
laughs. Doing but not showing is what allows 
her to be normal most of the time. While 
spending time with patients, it was 
sometimes hard to notice them doing any 
therapy at all over a day. Some strategies 
resemble technical fixes, like having a port 
inserted instead of an i.v. access or taking 
cortisone before going to nightclubs, where 
cigarette smoke could trigger a bronchial 
hyperreagibility and lead to the constriction 
of the airways.  
Some of the tactics they employ are quick 
cover-ups, like stuffing pills directly into a 
sandwich instead of taking them with liquids 
during a meal. Other tactics resemble 
Mimikri, for example using explanations like 
„It's sth. like Asthma“, a trope frequently 
employed by several of our collaborators 
when they were asked why they coughed 
instead of explaining CF. During those times 
when she needs IV antibiotics, Tanja would 
make the cotton covering the IV line on her 
forearm a little thicker, transforming it into a 
“sweat band” so that the line wouldn't be as 
visible. One day, she and a friend were asked 
about those „sweat bands“, while at a 
hairdresser who remarked that they had an iv 
line underneath them. Tanjas friend told us 
the hairdresser had inquired if they were 
taking methadone because they looked so 
pale. She sighed, stating that being taken for 
one who is on a drug replacement programm 
which is clearly stigmatizing was still better 
then explaining CF to a casual encounter. 
Table 1 lists some strategies and tactics we 
found.  
Some challenges can be fixed using clever 
tactics, some by medical progress and some 
cannot be fixed at all. For some situations, like 
the direct transfer of oxygen to the lungs, 
which some patients require, such quick 
cover-ups and mimicries cannot be applied. 
Inhalations need time to prepare and to be 




carried out. To clear the mucus, mobilised by 
inhaling, one needs to cough afterwards,  
because of the urge to do so caused by 
inhaling and because without coughing the 
mucus out, inhaling is considered medically 
useless.  
The strategies and tactics work out quite well 
most of the time, but they are precarious, and 
can fail at exactly the wrong moment, as we 









Table 1. Strategies and Tactics for managing the visibility of illness and therapy 
Strategies Example 
Technical fixes Smaller infusion pumps, port systems, gene-repair drugs (ivacaftor) 
Tactics  
Non-adherence Inhaling less in order to avoid prolonged coughing in public. 
Differential disclosure Using different levels of involvement and disclosure, like telling romantic 
partners and friends but not your boss. 
Oscillation  Switching between relating to CF as therapy being normal 
Mimicry Using explanations like „It's sth. like Asthma“, accepting being taken as 
on a drug replacement program instead of explaining CF iv-therapy. 
 
 
When tactics fail: dealing with the 
ambivalence  
What enables patients to participate in an 
apparently normal way is a permanent 
gestalt-switch between relating to CF as 
'therapy' or being normal. Problems with this 
arise when an element causes a gestalt-switch 
at a wrong moment: One day a friend of Tanja 
who was studying medicine slipped away at 
the break during a seminar at the hospital to 
get an i.v. line for her home antibiotic 
therapy. The old i.v. was clogged and she 
needed a new one quickly in order to get back 
to her seminar before it started again, so no-
one would ask questions. To repair it she had 
to improvise a 'hospital setting'. She went to 
get a new i.v. line on the ward and found 
someone to put it in place. But doing this 
during a short seminar break, time is of the 
essence. Placing a i.v. in a CF patient often 
requires patience. The aggressive antibiotics 
used to combat infection make it more 
difficult to find a good vein after each therapy 
round. At that very moment, no doctor had 
time. So another patient, who was also a 
doctor was recruited for the procedure. 
Straight afterwards, the moment she slides 
the infusion pump into her pocket, she is back 
to normal. It seems as if she is carrying the 
hospital in her pocket. 
This requires a lot of work, and it is risky. If it 
becomes apparent that one has an infusion 
pump in the pocket, all the skilful work of 




concealing will be futile. The desire to appear 
normal is so strong, that there are moments 
where patients would rather run the risk of 
seriously deteriorating their health than to 
disclose being ill through doing therapy.  
 
The next morning, after Tanja used her 
inhalation machine for half an hour while 
reading a book, we drove by the office were 
she had worked until recently. She recalled, 
“At work I had to justify myself whenever I 
was late – that I just did my inhalations and 
wasn't lazy. It's difficult to explain every time 
– even some people who work with you don't 
seem to understand.” Tanja remembered a 
colleague who had told her about how one of 
his acquaintances had gotten a renal 
transplant, and how horrible that idea was to 
him. “I was struck with disbelief”, Tanja said, 
shaking her head. “I told him I might need a 
lung transplant in the not so distant future. 
He didn't get it – perhaps I still look too 
good?” 
 
The more therapy young people like Tanja do, 
the better they look. But the better they look, 
the higher people’s expectations are 
regarding their level of functioning. As one of 
Tanja's friends, who is still working, told me 
during an interview: 
 I consider doing my therapy, in the way 
that it now fits into my life, as a 
disadvantage, because you don't belong to 
any group. You are not part of the ill 
ones…but neither are you part of the 
healthy ones. That makes it difficult, 
because you have to justify yourself 
whenever you try to integrate yourself [into 
either group]. You are not part of any 
group, and you have to excuse yourself for 
what you don't have – illness or health. 
 
Immigrants to health 
 As Kaufman (2010) has argued, in cases of 
serious and chronic illness, clinical practices 
contain the challenges for those who are ill to 
imagine certain kinds of futures in which 
one’s corporeality is central, and to choose 
among medical options in order to move 
toward one kind of future instead of others. 
The logic that places the needs of acute 
everyday life above long-term survival is 
deeply embedded in the social practices of an 
ableist society (Maynard 2006). Patients with 
a chronic condition do not want to survive, 
they want to live. Living with CF means 
dealing with ambivalence of visibility since, 
while visibility of illness excludes them from 
the group of the healthy ones, it is also a 
resource that can be used to gain support and 
care. Yet, this ambivalence can only be 
navigated purposefully to a certain extent. To 
many out-standers, the double status of 
someone with CF – who is at once inherently 
ill and apparently healthy – is un-intelligibility. 
Most will try to sort them into either group. 
The German philosopher Hans-Georg 
Gadamer (1993:171) romantically said that 
health is equal to a “self-forgotten state of 
abandonment to the future“. Kathy Charmaz 
(1981) once argued the experience of chronic 
illness to be a loss of self. As this paper has 
tried to show, those with a chronic condition 
like CF, who have 'never not had it' cannot be 
said to experience a loss of a healthy self 
(Williams 2009). Neither are they self 
forgotten. Being alive for them is a state of 
constant attention to their self and its 
presence in public, rehearsing their arsenal of 
tactics of disclosure and mimicry and 
oscillating between being normal and doing 
therapy. 
This constant oscillation between normality 
and therapy is line with an argument by 
Joseph Dumit (2002) who observes that since 
the 1990s the paradigm of “inherent health” 
and illness as deviation from the norm has 
been replaced by a notion of illness in which 
bodies are inherently ill and a precarious self 
arises that needs constant maintenance to 
keep symptoms at acceptable levels. Dumit 




proposes that through the treatment of a 
chronic disease, a precarious self arises that 
needs constant maintenance to keep 
symptoms at acceptable levels. The new 
'normality' is thus not a return to the previous 
set of symptoms, but a 'virtual normality that 
is dependent upon medication'.  
We would like to extend Dumits proposition. 
With the help of a very complex and 
demanding therapeutic regimen, people with 
CF are able to make the symptoms of their 
illness invisible, thus allowing them to acquire 
a new – albeit temporary – healthy self. They 
become 'immigrants to health', to turn 
around Susan Sontag's (1978) phrase. 
Acknowledging the burden of therapy they 
face, and claiming the kinds of social support 
to which they are entitled as 'disabled' 
persons, may come with the loss of a sense of 
belonging in the world of the able bodied. 
This was a kind of temporary citizenship that 
many young people deeply desired. 
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